Advocacy intelligence hub — real-time data for patient organizations
Peking University Third Hospital — NA
Shanghai Cell Therapy Group Co.,Ltd — PHASE1
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. — PHASE1, PHASE2
Universidad Nacional de Colombia — PHASE1
Shenzhen Geno-Immune Medical Institute — PHASE1, PHASE2
H. Lee Moffitt Cancer Center and Research Institute — EARLY_PHASE1
Shenzhen Geno-Immune Medical Institute — PHASE1
Zhen-Yu Ding — EARLY_PHASE1
H. Lee Moffitt Cancer Center and Research Institute — PHASE1
The First Affiliated Hospital of Nanchang University — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Boon Cher Goh
National University of Singapore
Ashley Ghiaseddin, MD, M.D
University of Florida
📍 GAINESVILLE, FL
John Yu, MD
Cedars-Sinai Medical Center
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Michal Lotem, MD
Hadassah Medical Organization
Susan K. Parsons, MD, MRP
Tufts Medical Center Cancer Center